Clinically, CLL occurs in two forms, one indolent, characterized by mutated IGHVH and low ZAP-70 levels, and one aggressive identified by unmutated IGHVH and high ZAP-70 levels [2,3]. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.